Utility of predischarge and one-month transvenous implantable defibrillator tests

Jeffrey J. Goldberger; George Horvath; Shmuel Inbar; Alan H. Kadish

doi:10.1016/S0002-9149(96)00882-X

Utility of predischarge and one-month transvenous implantable defibrillator tests

Jeffrey J. Goldberger, George Horvath, Shmuel Inbar, Alan H. Kadish

Medicine

Research output: Contribution to journal › Article

23 Scopus citations

Abstract

We evaluated the utility of performing predischarge implantable cardioverter-defibrillator (ICD) testing and ICD testing at 1 month in detecting ICD-related problems, identifying 4 patients with an unacceptable increase in defibrillation threshold. Given that ICD testing is noninvasive and has minimal (if any) associated risk, we recommend that predischarge and 1-month follow-up ICD testing should be performed after implantation.

Original language	English (US)
Pages (from-to)	822-826
Number of pages	5
Journal	American Journal of Cardiology
Volume	79
Issue number	6
DOIs	https://doi.org/10.1016/S0002-9149(96)00882-X
State	Published - Mar 15 1997

Fingerprint

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Cite this

Goldberger, J. J., Horvath, G., Inbar, S., & Kadish, A. H. (1997). Utility of predischarge and one-month transvenous implantable defibrillator tests. American Journal of Cardiology, 79(6), 822-826. https://doi.org/10.1016/S0002-9149(96)00882-X

@article{999f60608fcd4ef28b2e6ccc50c70c3b,

title = "Utility of predischarge and one-month transvenous implantable defibrillator tests",

abstract = "We evaluated the utility of performing predischarge implantable cardioverter-defibrillator (ICD) testing and ICD testing at 1 month in detecting ICD-related problems, identifying 4 patients with an unacceptable increase in defibrillation threshold. Given that ICD testing is noninvasive and has minimal (if any) associated risk, we recommend that predischarge and 1-month follow-up ICD testing should be performed after implantation.",

author = "Goldberger, {Jeffrey J.} and George Horvath and Shmuel Inbar and Kadish, {Alan H.}",

year = "1997",

month = mar

day = "15",

doi = "10.1016/S0002-9149(96)00882-X",

language = "English (US)",

volume = "79",

pages = "822--826",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Utility of predischarge and one-month transvenous implantable defibrillator tests

AU - Goldberger, Jeffrey J.

AU - Horvath, George

AU - Inbar, Shmuel

AU - Kadish, Alan H.

PY - 1997/3/15

Y1 - 1997/3/15

N2 - We evaluated the utility of performing predischarge implantable cardioverter-defibrillator (ICD) testing and ICD testing at 1 month in detecting ICD-related problems, identifying 4 patients with an unacceptable increase in defibrillation threshold. Given that ICD testing is noninvasive and has minimal (if any) associated risk, we recommend that predischarge and 1-month follow-up ICD testing should be performed after implantation.

AB - We evaluated the utility of performing predischarge implantable cardioverter-defibrillator (ICD) testing and ICD testing at 1 month in detecting ICD-related problems, identifying 4 patients with an unacceptable increase in defibrillation threshold. Given that ICD testing is noninvasive and has minimal (if any) associated risk, we recommend that predischarge and 1-month follow-up ICD testing should be performed after implantation.

UR - http://www.scopus.com/inward/record.url?scp=0030900639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030900639&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(96)00882-X

DO - 10.1016/S0002-9149(96)00882-X

M3 - Article

C2 - 9070573

AN - SCOPUS:0030900639

VL - 79

SP - 822

EP - 826

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 6

ER -

Access to Document

10.1016/S0002-9149(96)00882-X